S100B in Gulf War Illness

S100B, also described as Astrocyte protein, is a neurological marker with mixed findings in Gulf War Illness (GWI, Gulf War Syndrome): studies comparing patients with healthy Gulf War veteran controls report both increases and decreases. The cited literature links this alteration to neurological symptoms subset. The evidence summarised here comes from Gean et al. 2021 and reflects averages across cohorts rather than any single patient's result.

↕ InconsistentNeurological

Summary

Direction in Gulf War Illness↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryNeurological
Also described asAstrocyte protein
Compared againstHGV (healthy Gulf War veteran controls)
Associated symptomsNeurological symptoms subset
Test typeBlood test (serum / plasma / whole blood)
SourceGean et al. 2021 — doi:10.1016/j.lfs.2021.119456
Condition atlasGulf War Illness Biomarker Atlas

Other conditions where S100B is reported

See the cross-condition hub: S100B across conditions.

Related Neurological markers in Gulf War Illness

Full list: Gulf War Illness Biomarker Atlas.

Frequently asked questions

Is S100B high or low in Gulf War Illness?

Mixed. Some studies report higher and others lower S100B in Gulf War Illness compared with healthy Gulf War veteran controls, so no single direction is established. Source: Gean et al. 2021.

What symptoms is S100B associated with in Gulf War Illness?

The cited literature associates this marker with Neurological symptoms subset. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures S100B?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal S100B result diagnostic of Gulf War Illness?

No. No single biomarker is diagnostic of Gulf War Illness. S100B findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is S100B specific to Gulf War Illness?

No. The same marker is also reported in Epilepsy, Long COVID in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). S100B in Gulf War Illness: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/gulf-war-illness/s100b.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from gulf-war-illness.json · Browse: Gulf War Illness atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.